title: Chronical haloperidol and clozapine treatment in rats: differential RNA display analysis, behavioral studies and serum level determination.
abstract: 1. Adult, female rats were treated orally for 23 days with 1.6 mg/kg haloperidol or 36 mg/kg clozapine per day, to study chronic effects of the two neuroleptics. 2. At five time points during the neuroleptic treatment, animal behavior was recorded in an open field and locomotive activity was analysed. At the end of the experiment, rats were decapitated, blood samples were collected and serum concentrations of haloperidol and clozapine were determined by a radioreceptor or HPLC assay, respectively. RNA was isolated from each brain, without cerebellum, and subjected to differential RNA display. 3. Mean serum concentrations were 8 ng/ml for haloperidol and 21 ng/ml for clozapine. Analysis of open field behavior showed that haloperidol and clozapine decreased the total distance moved and the velocity as measures of the overall activity, whereas the number of rearings and the number of entries into the center, reflecting risk assessment behavior, were differentially affected. Three neuroleptic-regulated gene fragment bands were identified in differential RNA display experiments. Two gene fragments of 281 bp and 266 bp were sequenced. 4. We conclude that our study design that used behavioral, pharmacokinetic and molecular analysis increase the likelihood of finding relevant molecular events underlying the pharmacotherapeutic effects of neuroleptics in animal models.
authors.affiliation: Department of Psychiatry, University of Mainz, Germany.
authors.forename: V
authors.initials: V
authors.lastname: Fischer
authors.forename: U
authors.initials: U
authors.lastname: Schmitt
authors.forename: H
authors.initials: H
authors.lastname: Weigmann
authors.forename: B
authors.initials: B
authors.lastname: Von Keller
authors.forename: S
authors.initials: S
authors.lastname: Reuss
authors.forename: C
authors.initials: C
authors.lastname: Hiemke
authors.forename: N
authors.initials: N
authors.lastname: Dahmen
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000097:blood / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D003024:Clozapine / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology*; D017931:DNA Primers; D005260:Female; D006220:Haloperidol / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects*; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000032:analysis* / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D014150:Antipsychotic Agents; D017931:DNA Primers; D012333:RNA, Messenger; D003024:Clozapine; D006220:Haloperidol